These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4162668)

  • 41. [Sodium balance during fasting and realimentation with special reference to a form of therapy for obesity].
    Giocoli G
    Ann Ist Super Sanita; 1971; 7(4):613-25. PubMed ID: 5151231
    [No Abstract]   [Full Text] [Related]  

  • 42. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels.
    Hollister LE; Overall JE; Snow HL
    Am J Clin Nutr; 1967 Jul; 20(7):777-82. PubMed ID: 6036267
    [No Abstract]   [Full Text] [Related]  

  • 45. [Does short-term fasting lower the cardiovascular risk in obesity? Effects of the composition of the reducing diet].
    Kolb S; Sailer D
    Fortschr Med; 1983 Sep; 101(35):1550-3. PubMed ID: 6629289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
    Schneider H; Zschornak M; Neumann I; Haller H
    Z Gesamte Inn Med; 1981 Apr; 36(7):301-4. PubMed ID: 7281831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contraindications and therapeutic results of fasting in obese patients.
    Duncan GG; Duncan TG; Schless GL; Cristofori FC
    Ann N Y Acad Sci; 1965 Oct; 131(1):632-6. PubMed ID: 5216997
    [No Abstract]   [Full Text] [Related]  

  • 48. [Blood uric acid levels and overweight: correlations in clinical cases of diabetic patients].
    Sinagra D; Cangemi C; Lombardo G; Randazzo C
    Medicina (Firenze); 1988; 8(1):77-8. PubMed ID: 3226252
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hyperuricuria after fasting as a risk factor for the development of uric acid urolithiasis].
    Krízek V; Sadílek L
    Cas Lek Cesk; 1986 Apr; 125(16):478-80. PubMed ID: 3719622
    [No Abstract]   [Full Text] [Related]  

  • 50. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.
    Bonora E; Targher G; Zenere MB; Saggiani F; Cacciatori V; Tosi F; Travia D; Zenti MG; Branzi P; Santi L; Muggeo M
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):975-80. PubMed ID: 8923153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Influence of dietary habits and body weight on blood uric acid in the elderly].
    Tang D; Xia B
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):447-9. PubMed ID: 10682557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Absolute fasting in the treatment of obesity].
    Hartmann G
    Rev Med Suisse Romande; 1967 Sep; 87(9):647-62. PubMed ID: 4861870
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass.
    Drenick EJ; Simmons F; Murphy JF
    N Engl J Med; 1970 Apr; 282(15):829-34. PubMed ID: 5418545
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of ketogenic diet on body weight, intermediary and electrolyte metabolism of obese subjects].
    Chmidt H; Janik I; Voigt KD
    Dtsch Med Wochenschr; 1969 Jan; 94(2):78-82. PubMed ID: 5782695
    [No Abstract]   [Full Text] [Related]  

  • 55. Aggressive nutritional strategy in morbid obesity in clinical practice: Safety, feasibility, and effects on metabolic and haemodynamic risk factors.
    Castaldo G; Palmieri V; Galdo G; Castaldo L; Molettieri P; Vitale A; Monaco L
    Obes Res Clin Pract; 2016; 10(2):169-77. PubMed ID: 26044613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans.
    Hodge AM; Dowse GK; Zimmet PZ
    Int J Obes Relat Metab Disord; 1993 Jul; 17(7):399-407. PubMed ID: 8395475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prolonged fasting as a method of treating obesity].
    Hartmann G; Schmid R
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1663-8. PubMed ID: 4964148
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of obesity with a zero-calorie diet].
    Foldenauer A; Böhm P
    Munch Med Wochenschr; 1968 Oct; 110(41):2373-7. PubMed ID: 5761613
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
    Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
    J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Late results of weight reduction by complete fasting].
    Hermann LS; Nathan E; Iversen M; Gronboek P
    Ugeskr Laeger; 1969 Jan; 131(5):188-92. PubMed ID: 5772313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.